freie Wahl der Heilmittel
wissenschaftlich anerkannte Beurteilungmöglichkeit der Naturheilkunde
Thematic focus Cultural heritage
Nosodes
The European HMPWG
should review and reformulate
the official requirements for
Nosodes in a positive way!
Microbiological- and Phytotherapy
AMR
Microbiological Therapy and Phytotherapy
Best complementary medicine options
to reduce antibiotic treatment
Layer für Überschrift
Remedies

Focus on
remedies

Studydesign

Focus on
study design

Thematic focus free Treatment

Focus on
free treatment

Thematic focus Cultural heritage

Focus on
Cultural Heritage

Complementary and Alternative Medicine

ANME advocates for Complementary
and Alternative Medicine in Europe

Layer für Überschrift
previous arrow
next arrow
Shadow

Partner

who

 

Logo UNESCO Kommission Deutschland

 

epha 2016

 

ECAMP

 

SALUS Network

 

European Parliament, Brussels, Belgium 9.1.2018 – Report by Lauren Tuchman, ANME e.V.

This event at the European Parliament involved the European Medicines Agency (EMA) and was co-hosted by WEMOS (an independent civil society organization based in the Netherlands, whose aim is to improve public health worldwide)...

One intent behind this event was to discuss and understand how the European Medicines Agency (EMA) tackles the idea of transparency, and how the EMA is addressing and minimizing ‘conflicts of interest’. An additional focus was on a discussion of EMA’s openness/willingness to work toward greater attention, time, and allocation of resources to the idea of ‘added therapeutic value.’ This added therapeutic value could be applied to new medicines and independent clinical research as a precursor to decisions made on marketing authorization and acceptance of new pharmaceuticals; added therapeutic value could also aid in assessing, monitoring, enforcing safety, standardization, and accountability for those pharmaceuticals that are already approved and on the market.

Read on PDFanhang